Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy in the CNS.

L C Costantini1, J C Bakowska, X O Breakefield

  • 1Neuroregeneration Laboratory, Harvard Medical School, McLean Hospital, Belmont, MA, USA.

Gene Therapy
|February 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosome-based liquid biopsies in cancer: opportunities and challenges.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Integrated molecular landscape of Parkinson's disease.

NPJ Parkinson's disease·2017
Same author

Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.

Neuroscience·2016
Same author

In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells.

Molecular and cellular neurosciences·2015
Same author

Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.

Molecular neurobiology·2015
Same author

Characterization of monoamine oxidase activity during early stages of quail embryogenesis.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014

Gene therapy shows promise for neurological disorders by addressing genetic causes and slowing disease progression in animal models. Challenges in gene delivery and expression regulation in the brain remain key research areas.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Gene therapy is an experimental approach for treating neurological disorders.
  • Current goals include symptom relief, slowing disease progression, and correcting genetic defects.
  • Advances in molecular understanding and gene transfer are enabling new therapeutic strategies.

Purpose of the Study:

  • To review the current state and future potential of gene therapy for central nervous system (CNS) disorders.
  • To highlight experimental successes and ongoing challenges in the field.
  • To emphasize the need for collaborative research in CNS gene therapy development.

Main Methods:

  • Review of experimental studies and scientific literature on gene therapy for neurological conditions.

Related Experiment Videos

  • Analysis of gene transfer systems and delivery methods for the CNS.
  • Identification of limitations and challenges in current gene therapy approaches.

    • Main Results:

    • Experimental studies demonstrate the potential of gene therapy to achieve therapeutic goals in animal models.
    • Successful focal and global delivery of therapeutic genes for various CNS disorders has been achieved.
    • Key limitations include transgene expression stability/regulation and vector/transgene safety.

    Conclusions:

    • The brain presents unique challenges for gene therapy, including post-mitotic cells, cellular heterogeneity, and limited access.
    • Multiple gene delivery strategies will likely be required for effective CNS gene therapies.
    • Collaboration between clinicians and basic researchers is crucial for advancing CNS gene therapy.